7 Jul 2020 09:45
RNS Number : 2572S
Templeton Emerging Markets IT PLC
07 July 2020
Â
Templeton Emerging Markets Investment Trust PLC ("TEMIT")Â Â Â Â
    Â
On behalf of TEMIT, Franklin Templeton International Services S.a.r.l. reports the unaudited cum-income net asset value ("NAV") of TEMIT as at   Â
 06 July 2020 was £2241.706m, representing a NAV of 934.19 pence per share.Â
The unaudited ex-income NAV of TEMIT as at 06 July 2020 was £2203.968m, representing a NAV of 918.46 pence per share.
    Â
In accordance with the Association of Investment Companies recommendations, the cum-income NAV has been calculated based on the total value of underlying assets,   Â
including accumulated or accrued income, and using bid price information relating to the underlying assets.   Â
The ex-income NAV has been calculated based on the total value of underlying assets, excluding these income elements, and using bid price information relating to the underlying assets.   Â
    Â
The NAV of TEMIT is calculated daily at US close of markets using the latest available closing bid prices in each market of investment. However, where appropriate,   Â
these prices are adjusted to a fair value basis having regard to a range of market triggers and proxies.   Â
    Â
For information purposes only, if fair value at yesterday's US close had not been applied,   Â
The unadjusted cum-income NAV would have been, £2232.840m, representing a NAV of 930.50 pence per share. Â
and the unadjusted ex-income NAV would have been, £2195.102m, representing a NAV of 914.77 pence per share. Â
Portfolio data for TEMIT can be found on the website www.TEMIT.co.uk.   Â
    Â
If debt were valued at cost, the cum-income NAV would increase by 1.00p  Â
    Â
For information please contact Client Dealer Services on freephone 0800 305 306.   Â
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Â
ENDÂ
Â
NAVDZGGNRNFGGZG